|
Product class:
|
Medicinal product with marketing authorization
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Name of medicinal product:
|
Cytopoint
|
|
Active substances:
|
|
|
ATC code:
|
QD11AH91
|
|
Dosage form:
|
solution for injection
|
|
Strength:
|
20mg 1ml
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Summary of product characteristics (SPC):
|
|
|
Package information leaflet (PIL):
|
EST
|
|
Labelling:
|
|
|
Indication:
|
Treatment of pruritus associated with allergic dermatitis in dogs.
Treatment of clinical manifestations of atopic dermatitis in dogs.
|
|
Safety features:
|
No
|
|
Marketing authorization holder:
|
Zoetis Belgium
|
|
Marketing authorization number:
|
EU/2/17/205
|
|
Marketing authorization issued on:
|
April 27, 2017
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
Centralised
|
|
Assessment report:
|
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
|
1744815
|
Cytopoint
|
solution for injection
|
20mg 1ml 1ml 2TK
|
Prescription
|
|
|
17.11.2023
|
|
|
|
1744826
|
Cytopoint
|
solution for injection
|
20mg 1ml 1ml 6TK
|
Prescription
|
|
|
|
|
|
|
1831463
|
Cytopoint
|
solution for injection
|
20mg 1ml 1ml 1TK
|
Prescription
|
|
|
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere